Proarrhythmia Risk Assessment Using Electro-Mechanical Window in Human iPS Cell-Derived Cardiomyocytes.

Yanagida, Shota; Satsuka, Ayano; Hayashi, Sayo; Ono, Atsushi; Kanda, Yasunari

Yanagida, Shota; Satsuka, Ayano; Hayashi, Sayo; Ono, Atsushi; Kanda, Yasunari.

Afiliación

Yanagida S; Division of Pharmacology, National Institute of Health Sciences.
Satsuka A; Division of Pharmaceutical Sciences, Graduated School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
Hayashi S; Division of Pharmacology, National Institute of Health Sciences.
Ono A; Division of Pharmacology, National Institute of Health Sciences.
Kanda Y; Division of Pharmaceutical Sciences, Graduated School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.

Biol Pharm Bull ; 45(7): 940-947, 2022.

Article en En | MEDLINE | ID: mdl-35786601

Asunto(s)

Células Madre Pluripotentes Inducidas; Aspirina; Bepridil; Proteínas de Unión al ADN; Humanos; Mexiletine; Miocitos Cardíacos; Ranolazina; Medición de Riesgo

Palabras clave

Comprehensive in vitro Proarrhythmia Assay; cardiomyocyte; contractility; electro-mechanical window; induced pluripotent stem (iPS) cell; proarrhythmia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google